Young-Sook Song
Chief Executive Officer presso HANMI SCIENCE CO., LTD.
Patrimonio netto: 250 M $ in data 31/03/2024
Profilo
Young-Sook Song occupa la posizione di presidente e co-amministratore delegato di Hanmi Science Co. Si è laureata all'Università femminile di Sookmyung.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
HANMI SCIENCE CO., LTD
12.56% | 01/04/2024 | 8 789 671 ( 12.56% ) | 250 M $ | 31/03/2024 |
Posizioni attive di Young-Sook Song
Società | Posizione | Inizio |
---|---|---|
HANMI SCIENCE CO., LTD. | Chief Executive Officer | - |
Beijing Hanmi Pharmaceutical Co., Ltd.
Beijing Hanmi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Hanmi Pharmaceutical Co., Ltd., Beijing Hanmi Pharmaceutical Co., Ltd. is a pharmaceutical company based in Beijing, CN. Beijing Hanmi Pharmaceutical Co. specializes in respiratory, pediatric, digestive, orthopedic, and anti-infective drugs, among others. The Chinese company also has research centers and development alliances. The private company has a range of products, including probiotics for infants and young children, and medicine for respiratory diseases, cough, fever, and pain relief. The company is committed to social responsibility and has participated in various public welfare projects. The company was founded in 1996, and the CEO is Hai Long Ren. | Chairman | - |
Formazione di Young-Sook Song
Sookmyung Women's University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Beijing Hanmi Pharmaceutical Co., Ltd.
Beijing Hanmi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Hanmi Pharmaceutical Co., Ltd., Beijing Hanmi Pharmaceutical Co., Ltd. is a pharmaceutical company based in Beijing, CN. Beijing Hanmi Pharmaceutical Co. specializes in respiratory, pediatric, digestive, orthopedic, and anti-infective drugs, among others. The Chinese company also has research centers and development alliances. The private company has a range of products, including probiotics for infants and young children, and medicine for respiratory diseases, cough, fever, and pain relief. The company is committed to social responsibility and has participated in various public welfare projects. The company was founded in 1996, and the CEO is Hai Long Ren. | Health Technology |
Hanmi Science Co., Ltd. |
- Borsa valori
- Insiders
- Young-Sook Song